Who Benefits When Prescription Drug Manufacturers Offer Copay Coupons?

References

• Arcidiacono P, Landry P, Ridley D (1984) Pharmaceutical followers. Internat. J. Indust. Organ. 31(5):538–553.Crossref, Google Scholar
• Aydin G, Porteus E (2008) Manufacturer-to-retailer vs. manufacturer-to-consumer rebates in a supply chain. Agrawal N, Smith S, eds. Retail Supply Chain Management (SpringerLink, Berlin), 237–270.Crossref, Google Scholar
• Banks J, Moorthy S (1999) A model of price promotions with consumer search. Internat. J. Indust. Organ. 17(3):371–398.Crossref, Google Scholar
• Bergstrom T, Bagnoli M (2005) Log-concave probability and its applications. Econom. Theory 26(2):445–469.Crossref, Google Scholar
• Berndt ER, McGuire TG, Newhouse JP (2011) A primer on the economics of prescription pharmaceutical pricing in health insurance markets. Working paper, National Bureau of Economic Research, Cambridge, MA.Crossref, Google Scholar
• Bester H, Petrakis E (1996) Coupons and oligopolistic price discrimination. Internat. J. Indust. Organ. 14(2):227–242.Crossref, Google Scholar
• Bhattacharya J, Vogt W (2003) A simple model of pharmaceutical price dynamics. J. Law Econom. 46(2):599–629.Crossref, Google Scholar
• Chen X, Li C-L, Rhee B-D, Simchi-Levi D (2007) The impact of manufacturer rebates on supply chain profits. Naval Res. Logist. 54(6):667–680.Crossref, Google Scholar
• Cho S, McCartle K, Tang C (2009) Optimal pricing and rebate strategies in a two-level supply chain. Production Oper. Management 18(4):426–446.Crossref, Google Scholar
• Dafny L, Ody C, Schmitt M (2016) When discounts raise costs: The effects of copay coupons on generic utilization. Working Paper No. 22745, National Bureau of Economic Research, Cambridge, MA.Google Scholar
• Danzon PM (1997) Price discrimination for pharmaceuticals: Welfare effects in the US and EU. Internat. J. Econom. Bus. 4(3):1–21.Google Scholar
• Dickstein M (2014) Physician vs. patient incentives in prescription drug choice. Working paper, Stanford University, Stanford, CA.Google Scholar
• Duggan M, Scott-Morton F (2010) The effect of medicare part D on pharmaceutical prices and utilization. Amer. Econom. Rev. 100(1):590–607.Crossref, Google Scholar
• Foley P (2011) How copay coupons could raise prescription drug costs. Technical report, Pharmaceutical Care Management Association, Washington, DC.Google Scholar
• Frank R (2001) Prescription drug prices: Why do some pay more than others do? Health Aff. 20(2):115–128.Crossref, Google Scholar
• Fudenberg D, Tirole J (1991) Game Theory (MIT Press, Cambridge, MA).Google Scholar
• Gilman B, Kautter J (2007) Impact of multitiered copayments on the use and cost of prescription drugs among medicare beneficiaries. Technical report, Health Research and Educational Trust, Chicago.Google Scholar
• Grande D (2012) The cost of drug coupons. J. Amer. Medical Assoc. 307(22):2375–2376.Crossref, Google Scholar
• Jayawardhana J (2013) Direct-to-consumer advertising and consumer welfare. Internat. J. Indust. Organ. 31(2):164–180.Crossref, Google Scholar
• Jelovac I (2015) On the relationship between the negotiated prices of pharmaceuticals and the patients’ co-payment. Econom. Bull. 35(1):481–493.Google Scholar
• Joffe-Walt C (2009) One pill two pill, red pill blue pill. Someone Else’s Money: This American Life (Chicago Public Media, Chicago), vol. 392.Google Scholar
• Kouvelis P, Xiao Y, Yang N (2015) PBM competition in pharmaceutical supply chain: Formulary design and drug pricing. Manufacturing Service Oper. Management 17(4):511–626.Link, Google Scholar
• Lee CY (2015) A welfare analysis of copay coupons in pharmaceuticals. Working paper, Duke University, Durham, NC.Google Scholar
• Narasimhan C (1984) A price discrimination theory of coupons. Marketing Sci. 3(2):128–147.Link, Google Scholar
• Rector T (2003) Effect of tiered prescription copayments on the use of preferred brand medication. Medical Care 41(3):398–406.Crossref, Google Scholar
• Ross J, Kesselheim A (2013) Prescription-drug coupons—No such thing as a free lunch. New Engl. J. Medicine 369(13):1188–1189.Crossref, Google Scholar
• Shaffer G, Zhang Z (1995) Competitive coupon targeting. Marketing Sci. 14(4):395–416.Link, Google Scholar
• Shaffer G, Zhang Z (2002) Competitive one-to-one promotions. Management Sci. 48(9):1143–1160.Link, Google Scholar
• Yarin S (2015) Pharmaceutical copay assistance programs and patient drug choice: Biological specialty drugs. Working paper, Stanford University, Stanford, CA.Google Scholar